News and Views
Recent Price Movement and Market Context
On 13 March, Lincoln Pharmaceuticals witnessed a notable dip, falling ₹13.95 or 2.26% to close at ₹603.45. This decline forms part of a three-day losing streak during which the stock has shed approximately 4.4% of its value. Intraday, the share price touched a low of ₹596.40, marking a 3.4% drop from recent highs. While the stock remains above its 50-day, 100-day, and 200-day moving averages, it is currently trading below its 5-day and 20-day averages, signalling some short-term weakness.
Despite this recent underperformance, Lincoln Pharmaceuticals has outperformed broader benchmarks over multiple time horizons. Year-to-date, the stock has surged 24.89%, significantly outpacing the Sensex’s decline of 12.50%. Over one year, it ...
Read full news article
